A systematic review and meta-analysis evaluated the risk for obesity-related cancer associated with glucagon-like peptide-1 ...

A systematic review and meta-analysis evaluated the risk for obesity-related cancer associated with glucagon-like peptide-1 receptor agonists (GLP-1RAs) in patients with type 2 diabetes (T2D) or ...

A new study from researchers at Cambridge, Mass.-based Harvard University found that blockbuster GLP-1 drugs such as Ozempic and Zepbound may have a minimal effect on an individual’s risk of ...

Doctors say the class of medications that includes Ozempic and Zepbound still offers health benefits for people with diabetes ...

A WOMAN who has lost seven stone on Mounjaro injections has revealed the positive side effects which mean she’ll never stop ...

Recent findings of uranium-contaminated drinking water in Delhi have raised serious health concerns. A doctor explains the ...

Could popular GLP-1 drugs used to treat diabetes and obesity increase cancer risk? A large, new study suggests they likely do ...

In the spring of 2021, the cancer field was abuzz over research that suggested a simple early-detection blood test could find ...

What comes out of us says a lot about our health. Before you flush, check for these warning signs in the toilet bowl.

GLP-1 drugs like Ozempic and Wegovy have rapidly moved from niche diabetes treatments to blockbuster weight loss injections, ...

A 69-year-old man presented with a 2-year history of changes in bowel habits, including abdominal cramps, constipation, and ...

Cancer drug resistance is the devastating reason that treatments fail and cancers metastasize, spreading to distant sites ...